Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: TMS for Inhibition Enhancement in Schizophrenia [NA]

View source ↗

Summary

A recruiting clinical trial is investigating transcranial magnetic stimulation to enhance inhibitory control in people with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | NA | Status: RECRUITING